Gilead Sciences Inc
XMUN:GIS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gilead Sciences Inc
XMUN:GIS
|
US |
|
S
|
Schlumberger NV
F:SCL
|
US |
|
Uniti Group Ltd
ASX:UWL
|
AU |
|
E
|
Emerita Resources Corp
F:LLJA
|
CA |
|
S
|
Severn Trent PLC
F:SVT1
|
UK |
|
P
|
Pembina Pipeline Corp
NYSE:PBA
|
CA |
|
B
|
Banco Bilbao Vizcaya Argentaria SA
SWB:BBVA
|
ES |
|
Barings BDC Inc
NYSE:BBDC
|
US |
|
T
|
TAL Education Group
SWB:IZZ
|
CN |
|
E
|
Electricite de France SA
F:E2F
|
FR |
|
U
|
United Rentals Inc
F:UR3
|
US |
|
D
|
Danaher Corp
DUS:DAP
|
US |
|
S
|
Sumitomo Corp
F:SUMB
|
JP |
|
C
|
Coca-Cola Co
XMUN:CCC3
|
US |
|
I
|
Italtile Ltd
JSE:ITE
|
ZA |
|
D
|
D R Horton Inc
F:HO2
|
US |
|
H
|
Henkel AG & Co KGaA
SWB:HEN3
|
DE |
|
U
|
Uber Technologies Inc
F:UT8
|
US |
|
F
|
Fluor Corp
XMUN:FLU
|
US |
|
G
|
Globe Life Inc
F:TMJ
|
US |
|
C
|
China Shenhua Energy Co Ltd
SWB:IKF
|
CN |
|
Swiss Re AG
SIX:SREN
|
CH |
Wall St Price Targets
GIS Price Targets Summary
Gilead Sciences Inc
According to Wall Street analysts, the average 1-year price target for GIS is 137.84 EUR with a low forecast of 106.4 EUR and a high forecast of 161.87 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GIS's stock price target?
Price Target
137.84
EUR
According to Wall Street analysts, the average 1-year price target for GIS is 137.84 EUR with a low forecast of 106.4 EUR and a high forecast of 161.87 EUR.
What is the Revenue forecast for Gilead Sciences Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 4%.
What is the Gross Profit forecast for Gilead Sciences Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Gilead Sciences Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 8%.
What is the Pre-Tax Income forecast for Gilead Sciences Inc?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 19%.
What is the Net Income forecast for Gilead Sciences Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 9%.
